James Aries

FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AML

Jad Othman, Nicola Potter, Katya Mokretar et al. · Leukemia · 2023 · 48 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID‐19: disease control as an important factor relative to recent chemotherapy or anti‐CD20 therapy

Stephen Booth, Helen Curley, Csilla Várnai et al. · British Journal of Haematology · 2021 · 37 citations · Full text

Medicine, Hematology, Oncology +13

Venetoclax–based low intensity therapy in molecular failure of <i>NPM1</i>-mutated AML

Carlos Jiménez‐Chillón, Jad Othman, David Taussig et al. · Blood Advances · 2023 · 29 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Capacity and performance analysis of distributed enterprise systems

James Aries, Subhankar Banerjee, Marc S. Brittan et al. · Communications of the ACM · 2002 · 13 citations

Computing, Computer Systems, Distributed Systems +16

Retinoic acid–responsive CD8 effector T cells are selectively increased in IL-23–rich tissue in gastrointestinal GVHD

Jennifer Ball, Andrew Clear, James Aries et al. · Blood · 2020 · 13 citations · Full text

Life Sciences, Immunology, Pathology +13